GINKGO BIOWORKS, INC. enters SYNLOGIC, INC. with 6.34M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/21/2019ACC: 0000904454-19-000519
6.34M
Baseline shares
100% direct
6.34M
Direct ownership
1 position
2.55M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned6.34M
Total
6.34M direct6.34M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.34M | Direct |
| Total | 6.34M | 6.34M direct |
Derivative Holdings1
Class A Warrants to Purchase Common Stock
DirectUnderlying security
Common Stock
Underlying shares
2.55M
Shares owned
N/A
Exercise price
.01
Expiration
—
Exercise window
—
Total
Underlying
2.55M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Class A Warrants to Purchase Common Stock Direct | Common Stock | .01 | — | — | 2.55M | N/A |
| Total | 2.55M | 0.00 | ||||